论文标题：Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19

期刊： Frontiers of Medicine

作者：Linhua Zhao, Chuanxi Tian, Yingying Yang, Huifang Guan, Yu Wei, Yuxin Zhang, Xiaomin Kang, Ling Zhou, Qingwei Li, Jing Ma, Li Wan, Yujiao Zheng , Xiaolin Tong

发表时间：15 Dec 2023

DOI：10.1007/s11684-023-1040-8

微信链接：点击此处阅读微信文章

导 读

中国中医科学院广安门医院仝小林团队在Frontiers of Medicine发表综述论文《中医药防治COVID-19的实践与原理》（Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19）。本文系统回顾了中医药防治COVID-19的临床循证研究、作用机制、中西医结合治疗效果及 “武昌模式” 等创新实践，为中医药防治重大传染病提供了理论支撑与实践路径。

Traditional Chinese medicine (TCM) has played an important role in the prevention and treatment of coronavirus disease 2019 (COVID-19) epidemic in China. The integration of Chinese and Western medicine is an important feature of Chinese COVID-19 prevention and treatment. According to a series of evidence-based studies, TCM can reduce the infection rate of severe acute respiratory syndrome coronavirus 2 in high-risk groups. For patients with mild and moderate forms of COVID-19, TCM can relieve the related signs and symptoms, shorten the period of nucleic-acid negative conversion, and reduce conversion rate to the severe form of the disease. For COVID-19 patients with severe and critical illnesses, TCM can improve inflammatory indicators and blood oxygen saturation, shorten the hospital stay, and reduce the mortality rate. During recovery, TCM can improve patients’ symptoms, promote organ function recovery, boost the quality of patients’ life, and reduce the nucleic-acid repositive conversion rate. A series of mechanism research studies revealed that capability of TCM to treat COVID-19 through antiviral and anti-inflammatory effects, immune regulation, and protection of organ function via a multicomponent, multitarget, and multipathway approach.

中医学在中国COVID-19疫情防控中发挥了重要作用。中西医结合是中国抗击COVID-19的一个重要特点。一系列循证医学研究表明，中医药能够降低严重急性呼吸综合征冠状病毒2（SARS-CoV-2，简称新冠病毒）在高危人群中的感染率。对于轻型和普通型COVID-19患者，中医药可缓解相关体征和症状，缩短核酸转阴时间，并降低向重型疾病的转化率。对于重型和危重型COVID-19患者，中医药能够改善炎症指标和血氧饱和度，缩短住院时间，并降低死亡率。在康复期，中医药可改善患者症状，促进器官功能恢复，提高患者生活质量，并降低核酸复阳率。一系列作用机制研究表明，中医药能够通过多成分、多靶点、多途径的方式，发挥抗病毒、抗炎、免疫调节以及保护器官功能的作用，从而治疗COVID-19。

期刊介绍

Frontiers of Medicine专注于发表临床医学和基础医学领域的最新研究成果，旨在通过全球医疗专业人员之间的交流促进健康和医疗保健的发展。该刊采用严格的同行评审和编辑流程，确保发表的文章的科学准确性、新颖性和重要性。

原文信息

标题

Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19

作者

Linhua Zhao¹, Chuanxi Tian^1,2, Yingying Yang³, Huifang Guan⁴, Yu Wei^1,2, Yuxin Zhang¹, Xiaomin Kang^1,2, Ling Zhou¹, Qingwei Li¹, Jing Ma⁴, Li Wan^1,2, Yujiao Zheng⁵, Xiaolin Tong¹

机构

1. Institute of Metabolic Diseases, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China

2. Beijing University of Chinese Medicine, Beijing 100029, China

3. National Center for Integrative Medicine, China-Japan Friendship Hospital, Beijing 100029, China

4. College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China

5. College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, China

通讯作者

Xiaolin Tong

引用这篇文章

Linhua Zhao, Chuanxi Tian, Yingying Yang, Huifang Guan, Yu Wei, Yuxin Zhang, Xiaomin Kang, Ling Zhou, Qingwei Li, Jing Ma, Li Wan, Yujiao Zheng, Xiaolin Tong. Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19. Front. Med., 2023, 17(6): 1014–1029 https://doi.org/10.1007/s11684-023-1040-8

https://journal.hep.com.cn/fmd/EN/10.1007/s11684-023-1040-8

https://link.springer.com/article/10.1007/s11684-023-1040-8

感谢作者对Frontiers of Medicine的信任和支持。

《前沿》系列英文学术期刊

由教育部主管、高等教育出版社主办的《前沿》（Frontiers）系列英文学术期刊，于2006年正式创刊，以网络版和印刷版向全球发行。系列期刊包括基础科学、生命科学、工程技术和人文社会科学四个主题，是我国覆盖学科最广泛的英文学术期刊群，其中12种被SCI收录，其他也被A&HCI、Ei、MEDLINE或相应学科国际权威检索系统收录，具有一定的国际学术影响力。系列期刊采用在线优先出版方式，保证文章以最快速度发表。

中国学术前沿期刊网

http://journal.hep.com.cn